Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomized, controlled, phase 2b trial.

Copyright© 2023 熊本大学大学院生命科学研究部 呼吸器内科学分野 All rights reserved.